APP and Alzheimer disease: The soluble amyloid precursor protein beta (sAPPβ), a cleavage product of the amyloid precursor protein (APP), has been implicated in AD due to its role in the amyloidogenic pathway, which contributes to the formation of amyloid-beta plaques [19].